Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-21
2006-03-21
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07015240
ABSTRACT:
The invention relates to the use of photodynamic therapy (PDT) to treat macular edemas, including DME, CRVO and BRVO. It provides an alternative to photocoagulation and the disadvantages associated therewith.
REFERENCES:
patent: 5756541 (1998-05-01), Strong et al.
patent: 5798349 (1998-08-01), Levy et al.
patent: 6270749 (2001-08-01), Blumenkranz et al.
patent: 6599891 (2003-07-01), North et al.
patent: 2003/0083649 (2003-05-01), Margaron et al.
patent: WO 02/064163 (2002-08-01), None
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, “Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-Related Macular Degenearation with Verteporfin: One-Year Results of 2 Randomized Clinical Trials-TAP Report 1” Archives of Opthalmology 117(10):1329-1345 (1999).
Boyer, D.S., et al., “Efficacy of Verteporfin Photodynamic Therapy on Laser Induced Choroidal Neovascularization and the Ancillary Effect on Diabetic Microvasculopathy” IOVS, Meeting Info: Annual Meeting of the Association for Research in Vision and Opthalmology Fort Lauderdale, Florida, Apr. 29-May 4, 2001 42(4):S695 (2001).
Lovestam-Adrian, M., et al., “Photocoagulation of Diabetic Macular Oedema: Compilations and Visual Outcome” Acta Ophthalmologica Scandinavica 78(6):667-671 (2000).
Aiello, L. M., et al., “Diabetic Retinopathy” Chapter 26In Retina-Vitreous-Macula: Diabetic Retinopathy(Guyer et al., eds.) W.B. Saunders Co. pp. 316-344 (1999).
Early Treatment Diabetic Retinopathy Study Research Group, “Photocoagulation for Diabetic Macular Edema: Early Treatment Diabetic Retinopathy Study Report Number1” Arch Opthalmol 103:1796-1806 (1985).
Early Treatment Diabetic Retinopathy Study Research Group, “Early Photocoagulation for Diabetic Retinopathy: ETDRS Report Number 9” Opthalmology 98:766-785 (1991).
Ferris, F. L. and Davis, M. D., “Treating 20/20 Eyes with Diabetic Macular Edema” Arch Opthalmol 117(5):675-676 (1999).
Ferris, F. L. and Patz, A., “Macular Edema. A Complication of Retinopathy” Surv Ophthalmol 28(Suppl):452-461 (1984).
Klein, R., et al., “The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XI. The Incidence of Macular Edema” Opthalmology 96:1501-1510 (1989).
Hnik Peter
North Janice
Strong H. Andrew
Henley III Raymond J.
Morrison & Foerster / LLP
QLT Inc.
LandOfFree
Treatment of macular edema does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of macular edema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of macular edema will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607698